2021
DOI: 10.1002/dad2.12243
|View full text |Cite
|
Sign up to set email alerts
|

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease

Abstract: Introduction Unsupervised digital cognitive testing is an appealing means to capture subtle cognitive decline in preclinical Alzheimer's disease (AD). Here, we describe development, feasibility, and validity of the Boston Remote Assessment for Neurocognitive Health (BRANCH) against in‐person cognitive testing and amyloid/tau burden. Methods BRANCH is web‐based, self‐guided, and assesses memory processes vulnerable in AD. Clinically normal participants (n = 234; aged 50–… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
31
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1
1

Relationship

4
6

Authors

Journals

citations
Cited by 27 publications
(36 citation statements)
references
References 55 publications
5
31
0
Order By: Relevance
“…ASRT tests correlated moderately with a well-established test of verbal episodic memory, cognitive composites and clinician reported outcomes, indicating acceptable convergent validity, and with results comparable to, or better than, other studies of computerised or unsupervised remote assessments (3840). Correlations with the Logical Memory test and clinician reported outcomes were in the moderate range, with lower correlation coefficients linked to test invariance due to ceiling or floor-level performance on these assessments in cognitively unimpaired individuals.…”
Section: Discussionsupporting
confidence: 58%
“…ASRT tests correlated moderately with a well-established test of verbal episodic memory, cognitive composites and clinician reported outcomes, indicating acceptable convergent validity, and with results comparable to, or better than, other studies of computerised or unsupervised remote assessments (3840). Correlations with the Logical Memory test and clinician reported outcomes were in the moderate range, with lower correlation coefficients linked to test invariance due to ceiling or floor-level performance on these assessments in cognitively unimpaired individuals.…”
Section: Discussionsupporting
confidence: 58%
“…ASRT tests correlated moderately with a well-established test of verbal episodic memory, cognitive composites, and clinician-reported outcomes, indicating acceptable convergent validity, and with results comparable with, or better than, other studies of computerized or unsupervised remote assessments [ 41 - 43 ]. Correlations with LM and clinician-reported outcomes were in the moderate range, with lower correlation coefficients linked to test invariance owing to ceiling- or floor-level performance on these traditional clinical and neuropsychological assessments in CU individuals.…”
Section: Discussionsupporting
confidence: 56%
“…In addition, they were related to tests of A cognitive measure often used in the early stages of AD is the PACC, and earlier studies have already compared unsupervised cognitive assessments against the PACC in similar samples. For example, a composite measure of the Boston Remote Assessment for Neurocognitive Health (BRANCH) (19) was strongly correlated with the PACC5 (r = 0.62) in cognitively normal participants. Another recent study (34) used a composite of similar but not identical tasks as used in this study and demonstrated a strong correlation to PACC (r = 0.51) in cognitively normal individuals without cognitive complaints.…”
Section: Discussionmentioning
confidence: 99%